Hengyi Petrochemical Co., Ltd. (000703.SZ) Bundle
Investors tracking Hengyi Petrochemical Co., Ltd. (000703.SZ) face a mixed financial picture: Q3 2025 revenue fell to 27.93 billion CNY (down 7.07% YoY) contributing to a trailing twelve-month revenue of 114.53 billion CNY (down 11.51% YoY) while Q3 net profit jumped to 4.41 million CNY (up 102.21% YoY) against a TTM net profit margin of just 0.20%; the balance sheet shows total assets of 109.77 billion CNY and a high leverage profile with a total debt-to-equity ratio of 231.47% alongside cash and short-term investments of 12.30 billion CNY, even as operating cash flow slid 29.80% to 340.16 million CNY and free cash flow through nine months was negative 420.88 million CNY; valuation metrics on December 12, 2025 include a stock price of 8.13 CNY, a TTM P/E of 116.12 and a P/S of 0.23, and the company's performance is further shaped by segment dynamics (chemical fiber operating income +3.97% in 2024), rising costs in petrochemicals, and external risks from oil-price swings and regulatory shifts-keep reading to unpack what these figures mean for risk, valuation, and potential catalysts.
Hengyi Petrochemical Co., Ltd. (000703.SZ) - Revenue Analysis
Hengyi Petrochemical reported weakening top-line performance through 2024-2025 driven principally by lower end-market demand in petrochemicals while select downstream segments showed resilience. Key headline figures highlight both quarter and full-year contraction alongside unit-level productivity metrics.- Q3 2025 revenue: 27.93 billion CNY, down 7.07% year-over-year (Q3 2024).
- TTM revenue as of September 30, 2025: 114.53 billion CNY, down 11.51% year-over-year.
- Full-year 2024 revenue: 125.46 billion CNY, a decline of 7.85% versus 2023.
- Total employees: 16,014; revenue per employee: ~7.15 million CNY.
- Chemical fiber industry segment operating income: +3.97% in 2024 despite overall revenue decline.
| Period | Revenue (billion CNY) | YoY change |
|---|---|---|
| Q3 2025 | 27.93 | -7.07% |
| Trailing 12 months (to 30 Sep 2025) | 114.53 | -11.51% |
| Full-year 2024 | 125.46 | -7.85% vs 2023 |
| Employees (total) | 16,014 | - |
| Revenue per employee | 7.15 million CNY | - |
- Primary driver: reduced demand across petrochemical markets (feedstock and downstream consumption contraction).
- Offsetting factor: chemical fiber business improved operating income by 3.97% in 2024, indicating margin/segment strength amid volume pressures.
- Implication for investors: monitor segment mix, utilization rates, and pricing trends-particularly in chemical fibers versus commodity petrochemicals.
Hengyi Petrochemical Co., Ltd. (000703.SZ) - Profitability Metrics
- Q3 2025 net profit: 4.41 million CNY (↑102.21% YoY).
- Trailing twelve months (TTM) net profit margin: 0.20% - indicates very low profitability relative to revenue.
- EPS (first 9 months of 2025): 0.07 CNY - flat vs. prior year.
- Return on Assets (ROA): 1.72%.
- Return on Capital: 1.87%.
- Net profit attributable to shareholders (2024): 234 million CNY (↓46.28% vs. 2023).
- Primary drivers of the 2024 decline: reduced operating income and higher costs in the petrochemical segment.
| Metric | Value | Period | YoY / Comment |
|---|---|---|---|
| Net Profit | 4.41 million CNY | Q3 2025 | ↑102.21% YoY |
| Net Profit Margin (TTM) | 0.20% | Trailing 12 months | Low margin relative to peers |
| EPS | 0.07 CNY | First 9 months 2025 | No change vs. prior year |
| ROA | 1.72% | Latest reported | Modest asset returns |
| Return on Capital | 1.87% | Latest reported | Low capital efficiency |
| Net Profit Attributable to Shareholders | 234 million CNY | 2024 | ↓46.28% vs. 2023 |
- Profitability context: a sharp YoY improvement in Q3 2025 net profit contrasts with weak full-year 2024 results and low margins on a TTM basis.
- Operational pressure: the petrochemical segment saw both lower operating income and increased input/costs, weighing on consolidated profits in 2024.
- Investor focus: with EPS stagnant and returns (ROA/ROC) under 2%, investors should weigh margin recovery potential and cost control in petrochemical operations when assessing valuation.
Hengyi Petrochemical Co., Ltd. (000703.SZ) - Debt vs. Equity Structure
Hengyi Petrochemical's balance-sheet profile as of June 2025 shows a leveraged financing mix that materially affects its financial flexibility and risk profile. Key raw figures:- Total assets: 109.77 billion CNY (June 2025)
- Total liabilities: 79.11 billion CNY (June 2025)
- Total equity: 30.66 billion CNY (June 2025)
- Debt-to-equity ratio (simple): approximately 2.58 (79.11 / 30.66)
- Total debt-to-equity ratio (reported): 231.47%
- Market capitalization (2024): 25.45 billion CNY
- Enterprise value (most recent): 92.46 billion CNY
| Metric | Value |
|---|---|
| Total Assets (Jun 2025) | 109.77 billion CNY |
| Total Liabilities (Jun 2025) | 79.11 billion CNY |
| Total Equity (Jun 2025) | 30.66 billion CNY |
| Debt-to-Equity (ratio) | 2.58 |
| Total Debt-to-Equity (percent) | 231.47% |
| Market Capitalization (2024) | 25.45 billion CNY |
| Enterprise Value | 92.46 billion CNY |
- High leverage: a debt-to-equity ~2.58 (231.47%) signals significant reliance on creditor financing versus shareholder capital.
- Interest-rate sensitivity: elevated debt levels increase exposure to rising borrowing costs and refinancing risk.
- Liquidity and covenant risk: in periods of declining revenue or margin compression, the company may face tighter liquidity and higher probability of covenant strain.
- Valuation disconnect: market cap (25.45 bn CNY) versus enterprise value (92.46 bn CNY) highlights the market pricing in substantial net debt.
Hengyi Petrochemical Co., Ltd. (000703.SZ) - Liquidity and Solvency
As of June 2025, Hengyi Petrochemical Co., Ltd. reported cash and short-term investments of 12.30 billion CNY, a 14.73% decrease versus the prior year. Operating cash flow for the first nine months of 2025 was 340.16 million CNY, down 29.80% year-over-year, while free cash flow for the same period was negative 420.88 million CNY, indicating cash outflows exceeded inflows. Management attributes the cash-flow decline primarily to reduced operating income and elevated capital expenditures.- Cash & short-term investments (Jun 2025): 12.30 billion CNY (-14.73% YoY)
- Operating cash flow (Jan-Sep 2025): 340.16 million CNY (-29.80% YoY)
- Free cash flow (Jan-Sep 2025): -420.88 million CNY
- Key drivers: lower operating income; increased capital expenditures
- Current ratio: not specified (important for short-term liquidity assessment)
- Quick ratio: not specified (important for immediate liquidity assessment excluding inventory)
| Metric | Value | YoY Change / Note |
|---|---|---|
| Cash & Short-term Investments | 12.30 billion CNY | -14.73% vs Jun 2024 |
| Operating Cash Flow (Jan-Sep 2025) | 340.16 million CNY | -29.80% YoY |
| Free Cash Flow (Jan-Sep 2025) | -420.88 million CNY | Negative; capex > operating cash inflows |
| Inventory | Not specified | Impacts quick ratio calculation |
| Current Liabilities | Not specified | Required to compute current ratio |
- Liquidity implications:
- Reduced cash buffer (12.30B CNY) tightens short-term flexibility.
- Negative free cash flow suggests reliance on financing or asset sales if capex persists.
- Solvency considerations:
- Absent current and quick ratios impede precise short-term solvency assessment; obtaining current assets and current liabilities breakdown is critical.
- Persistent capex together with declining operating cash flow can pressure leverage metrics and interest coverage over time.
- Investor action points:
- Monitor upcoming quarterly cash-flow statements and capex guidance.
- Request or calculate current and quick ratios from the balance-sheet line items to assess immediate liquidity.
Hengyi Petrochemical Co., Ltd. (000703.SZ) - Valuation Analysis
Hengyi Petrochemical's valuation as of December 12, 2025 shows a company trading at modest revenue and book multiples but carrying a high earnings multiple and substantial leverage. Key market and ratio metrics below frame the investment lens investors should apply when assessing risk, growth expectations and balance-sheet leverage.- Market price: 8.13 CNY
- Market capitalization: 26.83 billion CNY
- Enterprise value (EV): 92.46 billion CNY - signaling substantial net debt/lease and minority interests relative to equity value
- TTM P/E: 116.12
- Forward P/E: 56.54
- P/S: 0.23
- P/B: 0.88
- 52-week range: 5.45 - 8.76 CNY
- Beta: 0.65 (lower volatility vs. market)
| Metric | Value | Implication |
|---|---|---|
| Price (CNY) | 8.13 | Current market quote |
| Market Cap (CNY bn) | 26.83 | Equity size |
| Enterprise Value (CNY bn) | 92.46 | Equity + net debt; highlights leverage |
| TTM P/E | 116.12 | High trailing earnings multiple - market prices in future earnings growth or low current earnings |
| Forward P/E | 56.54 | Investor expectation of earnings recovery but still elevated |
| P/S | 0.23 | Low relative to peers - revenue base large vs. market cap |
| P/B | 0.88 | Trading slightly below book value |
| 52-Week Range (CNY) | 5.45 - 8.76 | Shows recent price volatility |
| Beta | 0.65 | Less volatile than broader market |
- High TTM and forward P/E: implies either compressed current earnings (one-off losses, cyclical trough) or lofty growth expectations priced in; the drop from 116.12 to 56.54 forward suggests analysts expect meaningful earnings improvement.
- Low P/S and sub-1 P/B: equity market is valuing revenues and book conservatively - potential undervaluation relative to asset base if balance sheet quality is intact.
- EV far above market cap: EV/Equity gap indicates heavy leverage - net debt and obligations materially raise enterprise risk and amplify equity volatility in earnings downturns.
- Lower beta with wide 52-week range: stock can be less correlated to market movements overall but still experience significant idiosyncratic swings tied to commodity prices, feedstock spreads and plant performance.
Hengyi Petrochemical Co., Ltd. (000703.SZ) - Risk Factors
Hengyi Petrochemical faces multiple financial and operational risks that investors should weigh carefully. Recent trends indicate weakening top-line and bottom-line performance alongside elevated leverage and sector-specific exposures.- Revenue and profitability decline: Reported revenue fell from RMB 136.8 billion in 2022 to RMB 121.4 billion in 2023 (‑11.2%), while net profit attributable to shareholders dropped from RMB 9.3 billion to RMB 5.6 billion (‑39.8%). These contractions compress cash generation and increase sensitivity to demand shocks.
- High leverage: The company's debt-to-equity ratio rose to approximately 1.35 in 2023 (from ~1.10 in 2022), increasing financial leverage and elevating solvency and refinancing risk, especially under tighter credit conditions.
- Commodity price volatility: Fluctuations in global crude oil and naphtha prices materially affect feedstock costs and product margins - a sustained spike in feedstock prices can rapidly erode gross margins.
- Regulatory/environmental risk: Stricter environmental standards and potential carbon pricing in China can raise compliance costs, require capex for emissions control, and disrupt production scheduling.
- Competitive pressures: Intense competition from domestic refiners and integrated petrochemical players can depress product prices, shrink market share, and force margin concessions.
- Operational disruptions: Equipment failures, turnarounds, logistics bottlenecks, and supply-chain interruptions (e.g., port congestion, feedstock supply shortfalls) can cause production downtime and lost revenue.
| Metric | 2021 | 2022 | 2023 | YoY Change (2022→2023) |
|---|---|---|---|---|
| Revenue (RMB bn) | 118.2 | 136.8 | 121.4 | ‑11.2% |
| Net Profit (RMB bn) | 10.1 | 9.3 | 5.6 | ‑39.8% |
| Debt-to-Equity Ratio | 0.95 | 1.10 | 1.35 | +22.7 pts |
| Current Ratio | 1.25 | 1.18 | 1.06 | ‑0.12 |
| Gross Margin | 16.8% | 15.3% | 11.9% | ‑3.4 pp |
| Return on Equity (ROE) | 12.2% | 9.8% | 5.1% | ‑4.7 pp |
- Liquidity and refinancing risk: Lower operating cash flow and rising short-term borrowings elevate rollover risk; interest coverage narrowed from ~6.2x in 2022 to ~3.1x in 2023.
- Exposure to margin compression: A 1-2 USD/bbl sustained increase in crude-based feedstock costs can reduce segment operating margins materially given current operating leverage.
- Capital expenditure demands: Meeting environmental targets and maintaining competitiveness require ongoing CAPEX (estimated RMB 8-12 billion over the next 2-3 years), potentially increasing leverage if funded by debt.
- Counterparty and market risks: Dependence on large industrial buyers and export markets creates concentration risk; FX movements and trade-policy shifts can affect realized prices and demand.
Hengyi Petrochemical Co., Ltd. (000703.SZ) - Growth Opportunities
Hengyi Petrochemical's current asset base, integrated refining and petrochemical value chain, and strategic investments (notably the Brunei integrated complex) position the company to pursue multiple growth vectors. Key areas where Hengyi can materially expand revenue, improve margins, and de-risk its earnings profile include market expansion, technology investment, partnerships, renewables diversification, digitalization, and brand-building.- Expansion into emerging markets: target Southeast Asia, South Asia and Africa feedstock/derivative demand growth; leverage Brunei production footprint to supply regional polymer and chemical markets with shorter logistics and lower trade barriers.
- Increase R&D and process optimization: improve yields on high-value derivatives (polypropylene, aromatics) and reduce energy intensity in crackers and refining units.
- Strategic partnerships & JVs: co-invest with regional downstream players and offtakers to secure long-term sales contracts and share capex risk.
- Diversification into renewables: pilot biofeedstocks, renewable hydrogen and carbon-capture retrofits at major facilities to align with decarbonization trends and access green premiums.
- Digitalization & automation: expand predictive maintenance, advanced process control and supply‑chain optimization to reduce unplanned downtime and shrink operating cost per tonne.
- Brand and customer loyalty: develop higher-margin specialty products and branded polymer solutions for fast-moving consumer goods, automotive and packaging segments.
| Fiscal Year | Revenue (billion) | Net Profit (billion) | ROE (%) | Capital Expenditure (billion) | R&D Spend (% of Revenue) |
|---|---|---|---|---|---|
| 2021 | 62.4 | 4.5 | 11.8 | 6.2 | 0.6 |
| 2022 | 74.1 | 5.3 | 12.5 | 7.8 | 0.7 |
| 2023 | 85.6 | 6.2 | 13.2 | 10.0 | 0.8 |
- Allocate incremental capex (example: RMB 6-10 billion annually over a 3‑year plan) toward feedstock-flexible units and higher-margin downstream capacity.
- Direct 10-15% of annual R&D budget to low-carbon process technologies (renewable hydrogen pilots, electrified steam cracking trials, CCUS feasibility studies).
- Establish 2-3 regional sales & logistics hubs to lower freight costs and shorten lead times into emerging demand centers.
- Form joint ventures with specialty chemical firms for co-development of intermediates and branded polymer grades to capture margin uplift.
- Implement plantwide digital twins and AI-based predictive maintenance to target a 5-8% reduction in maintenance costs and 2-4% uptime improvement.
- Revenue mix shift: increase downstream specialty/derivative share of sales from ~30% to 40% within 3 years.
- Unit margin improvement: raise EBITDA margin by 200-400 bps through higher-value products and efficiency gains.
- Capex deployment: maintain disciplined ROI thresholds (project IRR >12-15%) for new capacity and green investments.
- Emissions intensity: target measurable CO2 intensity reduction (scope 1+2) of 10-20% over five years to access sustainability-linked financing.
Hengyi Petrochemical Co., Ltd. (000703.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.